🟢 EIQ.AX is trading 30% up today on Pro Medicus funding and US reseller partnership

EIQ.AX is trading 30% up at $1.61 after announcing a strategic funding and commercial deal with Pro Medicus.

• Echo IQ has secured a binding framework for up to A$20 million in secured convertible note funding to accelerate US commercialisation and international growth.
• The deal includes a proposed US reseller partnership for the EchoSolv HF cardiac AI platform, significantly expanding its distribution potential and market reach.
• The market reaction reflects strong investor confidence in the capital injection and the strategic validation provided by the partnership with Pro Medicus.